Sort
261,768 grants matching “gene therapy”
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
$1,476,414William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
$1,476,033Daniel Woo · University Of Cincinnati · U01 · FY2020 · NS
Genetic Engineering of Myeloid Cells to Treat Cancer
$1,476,000Julia C Carnevale · University Of California, San Francisco · DP2 · FY2025 · CA
Engineering enhanced erythropoiesis for red blood cell disorders
$1,476,000Michael Kyle Cromer · University Of California, San Francisco · DP2 · FY2025 · HL
High-resolution approaches to dissect the role of subcellular redox circuits in vivo
$1,476,000Javier Garcia Bermudez · Ut Southwestern Medical Center · DP2 · FY2024 · GM
Therapeutic evaluation in ovarian and breast cancer GEM-GDA models
$1,475,743Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Molecular Basis of Viral and Cellular Transformation
$1,475,716Daniel Dimaio · Yale University · P01 · FY2010 · CA
Discovery of genes required for expression or activity of fusion oncogenes
$1,475,356Natasha Caplen · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Cancer Center Support Grant
$1,475,182Michael J Weber · University Of Virginia · P30 · FY2009 · CA
Pathogenesis and Therapy of Chronic Lung Rejection
$1,475,127University Of Minnesota Twin Cities · P01 · FY2004 · AI
alpha-Synuclein and LRRK2 in the Pathogenesis of Parkinson's Disease
$1,475,093Jie Shen · Brigham And Women'S Hospital · P50 · FY2015 · NS
Characterization and improvement of graft versus leukemia effects
$1,475,058Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Immunobiology and immunotherapy of leukemia
$1,475,058Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
DNA Repair in Human Cancer-Prone Genetic Diseases
$1,475,023Kenneth H Kraemer · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Gene and Cell Therapy of Duchenne Muscular Dystrophy
$1,474,970University Of Pittsburgh At Pittsburgh · U54 · FY2004 · AR
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
$1,474,913Zhi-Ming Zheng · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
Characterization of epidermal stem cells: biology, carcinogenesis, and function
$1,474,513Raymond W Tennant · Environmental Health Sciences · Z01 · FY2007 · ES
Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery
$1,474,145Martin R. Pollak · Beth Israel Deaconess Medical Center · RC2 · FY2022 · DK
Interventional approaches for restoring vision
$1,474,118Anand Swaroop · National Eye Institute · ZIA · FY2014 · EY
Cross-Species and Evolutionary Biology
$1,474,040Ryan Tewhey · Translational Genomics Research Inst · U19 · FY2024 · AG
Anti IL5 and Churg Strauss Syndrome: a double blind, placebo controlled trial
$1,474,019Michael E Wechsler · National Jewish Health · U01 · FY2015 · AI
Preclinical and Early Clinical Development of a Novel Drug for On-Demand Voiding
$1,473,895Edward Burgard · Dignify Therapeutics, Llc · U44 · FY2024 · NS
Development Of Theoretical Methods For Studying Biological Macromolecules
$1,473,710Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
$1,473,606Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · U54 · FY2023 · CA
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
$1,473,388Estuardo Aguilar-Cordova · Advantagene, Inc · R44 · FY2009 · CA